Simian Foamy Virus Transmission to Humans

About three quarters of the viral agents that have emerged recently in humans are considered to originate from other animals. These viruses have often evolved and spread into the human population through various mechanisms after the initial contact that resulted in interspecies transmission. However, knowledge of the initial stages of the emergence of viruses and associated diseases is still limited in many cases. Microbiological monitoring in populations at risk of transmission would provide insights into the initiation and early stages of the emergence process.

Nonhuman primates (NHPs) share many genetic, physiological, and microbiological features with humans, and are potential sources of many infectious agents. This has been demonstrated for several simian retroviruses. HIV-1 and 2 are believed to have originated from chimpanzee and mangabey viruses, respectively, found in Central and West Africa. The current distribution of the various molecular subtypes of the HTLV-1 oncogenic retrovirus in Africa is mainly the result of numerous instances of interspecies transmission of STLV-1from NHP species in the distant past.

Foamy viruses belong to the Retrovidae family and the Spumavirus genus. They are complex exogenous retroviruses and are very common in many animal species, including primates, cats, cattle, and horses, in which they cause persistent infections.

The first aim of the work is to study the epidemiological and molecular aspects of the transmission of foamy viruses from monkeys to humans in populations at risk, such as the inhabitants (especially hunters) in the villages of the dense forests of southern Cameroon. It is an area in which NHPs are still very common, with a great diversity of species. The investigators have already shown that the prevalence of foamy viruses is very high in these monkeys and great apes (gorillas and chimpanzees). Contact between these monkeys and the villagers is very frequent, mainly during hunting. The second aim of the project is to study the clinical and biological features of infected people and investigate intrafamilial transmission from infected index cases.

BACKGROUND A large proportion, about 75%, of the viral agents that have emerged recently in humans have originated from other animals. Following the initial contact resulting in interspecies transmission, these viruses have often evolved and spread through the human population; various mechanisms are involved, but the understanding of the initial stages of the emergence of viruses and associated diseases is still limited in many cases.

Microbiological monitoring in populations at risk of transmission is required to identify and document the initiation and early stages of the emergence process.

Nonhuman primates (NPHs), which share many genetic, physiological, and microbiological similarities with humans, are a potential source of many infectious agents.

This has been clearly demonstrated for several simian retroviruses: HIV-1 and 2 are believed to have originated from chimpanzee and mangabey viruses, respectively, in Central and West Africa. The distribution of the various molecular subtypes of the oncogenic retrovirus HTLV-1 in Africa is mainly the result of the pattern of interspecies transmission of STLV-1 from various NHP species in the distant past.

Foamy viruses belong to the retrovidae family and the spumavirus genus. They are complex exogenous retroviruses and are very common in many animal species, including primates, cats, cattle, and horses, in which they cause persistent infections.

Foamy viruses are generally non-pathogenic, even in experimentally infected animals. They do not appear to cause disease in the few humans who have been accidentally infected and clinically and biologically followed-up long-term (fewer than 15 people have been followed to date and they were originally healthy such that there is a selection bias). The absence of pathogenicity in vivo contrasts with the strong cytopathogenic effects of foamy virus in vitro where they cause syncytia in cell cultures.

Unlike lentiviruses (HIV-SIV), foamy viruses are extremely genetically stable in vivo. Phylogenetic analysis has demonstrated genetic variability, depending on the animal species infected. This indicates long coevolution of these retroviruses with their natural hosts. Switzer et al., showed that foamy viruses have coevolved with old world primates for at least 30 million years (Switzer et al. 2005). These data may explain the apparent absence of pathogenicity in vivo despite chronic infection.

The molecular characteristics of foamy viruses have been extensively studied in vitro, but little is currently known about the characteristics of these viruses in vivo, and in particular, about the epidemiological determinants of infection. Indeed, the modes of contamination and the characteristics of the primary infection in humans under natural conditions are still poorly understood.

The rare epidemiological data published are mostly for populations of captive NHPs: the seroprevalence of foamy viruses can reach 75% or more in adults in these populations. Several studies have shown that the saliva of infected animals has high titers of the virus, suggestive of the mode of transmission. The mucosa of the oropharynx is an important site of replication in green monkeys and a recent article reports high levels of viral RNA in saliva and oropharyngeal specimens from macaques. These observations suggest that bites or contact with oral mucosa and saliva can be transmission mechanisms, at least in some cases. Other studies in colonies of captive baboons suggest that transmission can be sexual and/or from mother to child through repeated salivary contact.

Human infection with foamy viruses has been reported: 1 to 4% of people professionally exposed to NHP (such as veterinarians, and personnel who work in animal houses, zoos, and primatology laboratories) in North America and, more rarely, in Europe may be infected.

An American group has shown infection by foamy viruses, originating from gorillas and mandrills, in some hunters living in Cameroon (Wolfe et al. 2004). Some cases of infection have been demonstrated in people in Southeast Asia in contact with monkeys (especially macaques): people working in temples, especially in Indonesia, or involved in hunting or other activities that put them in close contact with monkeys. Mathematical models have estimated that approximately six per 1000 temple visitors in Bali, Indonesia, where there are many macaques, have been infected with a simian foamy virus (Engel et al. 2006).

The long-term collaboration betwwen the investigators, the Pasteur Center of Cameroon, the IRD, and the University of Yaounde I, using serological and molecular techniques (PCR), has demonstrated foamy viruses in wild populations of gorillas, chimpanzees, mandrills, and drills in Cameroon. Adult populations of NHPs in these regions are highly infected with foamy viruses, with a specific virus for each species (Calattini et al. 2004 , Calattini et al. 2006b).

Consistent with the American study cited above, the investigators have demonstrated infection of hunters by the foamy viruses found in gorillas, chimpanzees, and mandrills after having been in contact with these primates (Calattini et al. 2007).

The EPVO unit at Institut Pasteur has been working in close collaboration with the Pasteur Center of Cameroon and the IRD for more than 15 years on numerous epidemiological studies in the field of the human retroviruses HTLV-1 (Mahieux et al. 2000b, Mauclere et al. 1997), HTLV-2(Gessain et al. 1995, Mauclere et al. 1995), the simian retroviruses STLV-1 and STLV-3 (Mahieux et al. 2000a, Meertens et al. 2002, Meertens et al. 2001, Meertens et al. 2003, Nerrienet et al. 2004, Nerrienet et al. 2001), and HTLV-3 (Calattini et al. 2009, Calattini et al. 2006a, Calattini et al. 2005).

The human populations studied are primarily in southern Cameroon. The investigators will continue to focus on several populations of southern Cameroon to gather further information on risk factors for the acquisition of foamy retroviruses following contact with NHPs.

These populations live close to, or in, dense rainforest areas. They are particularly at risk, due to the high biodiversity of NHPs in these regions. The greatest risk comes from relatively frequent contact with NHPs when hunting, which is for both consumption and sale of bushmeat.

OBJECTIVES The project presented herein consists of four phases. These phases can be carried out simultaneously.

Principal objective (phases 1 and 2) The purpose of this work is to carry out a serological and molecular survey to assess the prevalence of foamy virus infection in people at risk of contact with monkeys and to characterize risk factors for interspecies transmission.

This project corresponds to microbiological monitoring and, in particular, the study of the first stages of viral emergence.

Secondary objectives (phases 3 and 4)

1. Investigate possible intrafamilial transmission of foamy viruses from index cases, who all acquired the virus by being bitten by a great ape.
2. Investigate possible biological (especially immuno-virological) and clinical abnormalities in infected individuals through a case-control study. This will require a minimum of 30 index cases and 30 to 60 controls, if possible.

ORGANISATION OF THE STUDY The value and importance of this work on viral emergence will be presented to both administrative and traditional (village chief) local authorities. The investigators will work in three regions of southern Cameroon: the coastal region (Bipindi/Lolodorf/Campo), a more central region (Djoum/Oveng/Mintom/Akonolinga/Somolamo), and in the East in the region of Abong-Mang, Lomié, and Messok.

In these forested areas, the investigators work in Bantu villages (Ngoumba, Fang, Mvae, Zimé, etc.) and with the two different populations of Pygmies, the Bakolas in the West and the Bakas in the East.

Information is provided to each individual and the written consent of all participants collected by physicians.

In Phase 1 of the project, the study is proposed to all adults. There is no selection. A physical examination and blood draw into a 5/10 ml EDTA tube are performed.

In Phase 2, the investigators will specifically search for adults who have been in contact with a NHP during their lifetime. These contacts may include bites, scratches, or other injuries during hunting, or casual encounters with NHPs. An examination and blood draw in a 5/10 ml EDTA tube are performed. The epidemiological data on risk factors are collected through a short questionnaire.

In Phase 3, the investigators will perform a second visit to extend the survey to the nuclear family of infected individuals (spouse and children). An examination and blood draw into a 5/10 ml EDTA tube are performed (Table 1).

During Phase 4, additional clinical and biological examinations will be carried out on infected individuals at the Pasteur Center of Cameroon in Yaoundé (Phase 4). During this visit, saliva is collected. Oral specimens will be collected by rubbing the inside of the cheek with a swab and then rinsing the mouth and collecting the rinse liquid in a sterile bottle. Blood will be collected for further studies. Accommodation in Yaoundé, transportation, and meals of the subjects will be covered by EPVO.

The family study to detect the possible transmission of the virus, and the clinical and biological case-control study, will be carried out during the second phase, if sufficient infected people are detected during the first sero-epidemiological and virological survey.

The EPVO unit at Institut Pasteur is fully responsible for the organization and execution of the field work with logistical support from the IRD (renting a vehicle with driver) and the CPC (reception at the virology laboratory). Prof Antoine Gessain coordinates the project in Paris and Cameroon, and Dr. Edouard Betsem organizes the work in Cameroon.

The samples are aliquoted. Two aliquots of plasma and a peripheral blood buffy coat preparation are frozen at the Pasteur Center in Cameroon. In some cases, peripheral blood mononuclear cells will be obtained on Ficoll and then cultured.

These samples are then sent to the Institut Pasteur in Paris by air, according to current transport standards.

Back in Paris, biological tests and statistical analysis are performed by members of the EPVO unit.

Eligibility Criteria:
Inclusion Criteria:

* Living in a rural zone of Cameroon
* Being \> 5 yrs old
* Having received study information and having provided written consent for self and children, if applicable (for all phases)

Exclusion Criteria:

* Having refused to provide consent
* Being less than 5 years old